User profiles for Carmen Valenzuela
Carmen ValenzuelaInstituto de Investigaciones Biomedicas Alberto Sols CSIC-UAM Verified email at iib.uam.es Cited by 4690 |
Pharmacology of cardiac potassium channels
Cardiac K + channels are membrane-spanning proteins that allow the passive movement of
K + ions across the cell membrane along its electrochemical gradient. They regulate the …
K + ions across the cell membrane along its electrochemical gradient. They regulate the …
Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes
Background Bupivacaine is a potent local anesthetic widely used for prolonged local and
regional anesthesia. However, accidental intravascular injection of bupivacaine can produce …
regional anesthesia. However, accidental intravascular injection of bupivacaine can produce …
ω-3 and ω-6 polyunsaturated fatty acids block HERG channels
…, M David, T González, C Valenzuela - American Journal of …, 2005 - journals.physiology.org
Dietary polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic
properties, which have been attributed to their availability to modulate Na + , Ca 2+ , and …
properties, which have been attributed to their availability to modulate Na + , Ca 2+ , and …
[PDF][PDF] Stereoselective block of a human cardiac potassium channel (Kv1. 5) by bupivacaine enantiomers
Stereoselective drug-channel interactions may help to elucidate the molecular basis of
voltage-gated potassium channel block by local anesthetic drugs. We studied the effects of the …
voltage-gated potassium channel block by local anesthetic drugs. We studied the effects of the …
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
…, JL Marcelo, K Cosme, M Cruz, C Valenzuela… - Molecular and cellular …, 2008 - Springer
Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human
tumors. Here, we hypothesized that a peptide binder to the CK2 phosphoacceptor site could …
tumors. Here, we hypothesized that a peptide binder to the CK2 phosphoacceptor site could …
[PDF][PDF] Heberprot-P: a novel product for treating advanced diabetic foot ulcer
…, E López, PA López, A Río, C Valenzuela… - MEDICC …, 2013 - SciELO Public Health
Diabetic foot ulcer is a principal diabetic complication. It has been shown that diabetic
patients have decreased growth factor concentrations in their tissues, particularly epidermal …
patients have decreased growth factor concentrations in their tissues, particularly epidermal …
Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences
…, R Vicente, N Comes, C Valenzuela… - Journal of General …, 2010 - rupress.org
Voltage-dependent potassium (K v ) channels play a pivotal role in the modulation of
macrophage physiology. Macrophages are professional antigen-presenting cells and produce …
macrophage physiology. Macrophages are professional antigen-presenting cells and produce …
On the Molecular Nature of the Lidocaine Receptor of Cardiac Na+ Channels: Modification of Block by Alterations in the α-Subunit III-IV Interdomain
PB Bennett, C Valenzuela, LQ Chen… - Circulation research, 1995 - Am Heart Assoc
The mechanism of inhibition of Na + channels by lidocaine has been suggested to involve
low-affinity binding to rested states and high-affinity binding to the inactivated state of the …
low-affinity binding to rested states and high-affinity binding to the inactivated state of the …
Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1. 3 voltage-dependent potassium channels
…, D Parra, C Soler, N Comes, C Valenzuela… - Biochemical …, 2010 - Elsevier
Kv1.3 plays a crucial role in the activation and proliferation of T-lymphocytes and macrophages.
While Kv1.3 is responsible for the voltage-dependent potassium current in T-cells, in …
While Kv1.3 is responsible for the voltage-dependent potassium current in T-cells, in …
[HTML][HTML] Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical …
AM Solares, A Santana, I Baladrón, C Valenzuela… - BMC cancer, 2009 - Springer
Background Cervical cancer is now considered the second leading cause of death among
women worldwide, and its incidence has reached alarming levels, especially in developing …
women worldwide, and its incidence has reached alarming levels, especially in developing …